Europe approves first biosimilar antibody drug
LONDON (Reuters) - The European Commission has approved the first copycat version of an antibody-based drug, clearing the way for increased competitio...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/po_TDuNovz4/story01.htm
No comments:
Post a Comment